News tagged with olanzapine
Olanzapine
Olanzapine (trade names Zyprexa, Zalasta, Zolafren, Olzapin, Oferta, Zypadhera or in combination with fluoxetine Symbyax) is an atypical antipsychotic, approved by the FDA for the treatment of schizophrenia and bipolar disorder. Olanzapine is structurally similar to clozapine, but is classified as a thienobenzodiazepine. The olanzapine formulations are manufactured and marketed by the pharmaceutical company Eli Lilly and Company, whose patent for olanzapine proper expires in 2011 (in October 2009 a Canadian judge ruled that the 1991 patent was invalid). Sales of Zyprexa in 2008 were $2.2B in the US alone, and $4.7B in total.
For more information about Olanzapine, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Schizophrenia drugs raise the volume of a key signaling system in the brain
All the major groups of medications for schizophrenia turn up the volume of a brain signal known to be muted in individuals with this psychiatric disorder -- a signal that also can be influenced by diet. "This ...
Medicine & Health / Neuroscience
May 12, 2010 |
5 / 5 (3) |
3
|
Use of antipsychotic medications by children and adolescents associated with significant weight gain
Many pediatric and adolescent patients who received second-generation antipsychotic medications experienced significant weight gain, along with varied adverse effects on cholesterol and triglyceride levels and other metabolic ...
Medicine & Health / Medications
Oct 27, 2009 |
5 / 5 (2) |
0
Clinical study shows promising approach for preventing chemotherapy-induced nausea and vomiting
(PhysOrg.com) -- A phase three clinical trial directed by Rudolph M. Navari, director of the University of Notre Dame’s Walther Cancer Institute, demonstrated that a novel combination of drugs appears to be very successful ...
Jun 11, 2010 |
5 / 5 (1) |
1
